BioPharma Resources

Drug Trial Radar · NCT06419374

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ENLIGHTEN-Cirrhosis)

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,800 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,800

Planned (sponsor's estimate)

Start

May 24, 2024

Primary completion

Jun 30, 2028

Study completion Aug 31, 2031

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
May 17, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will assess the efficacy and safety of pegozafermin administered in participants with biopsy-confirmed and clinically confirmed compensated cirrhosis due to MASH .

Conditions

  • Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Interventions

  • PegozaferminBiological

    Subcutaneous injection

  • PlaceboDrug

    Subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Participants Achieving Fibrosis RegressionTime frame: Baseline through Month 24
  2. Time to First Occurrence of Disease Progression as Measured by Composite of Protocol -Specified Clinical EventsTime frame: Baseline up to 5 years

Locations

335 sites in 25 countries. Site status is shown where the registry gives one.

  • 89bio Clinical Study Site

    Birmingham, Alabama · Recruiting

  • 89bio Clinical Study Site

    Homewood, Alabama · Recruiting

  • 89bio Clinical Study Site

    Chandler, Arizona · Recruiting

  • 89bio Clinical Study Site

    Flagstaff, Arizona · Withdrawn

  • 89bio Clinical Study Site

    Peoria, Arizona · Recruiting

  • 89bio Clinical Study Site

    Phoenix, Arizona · Recruiting

  • 89bio Clinical Study Site

    Sun City, Arizona · Recruiting

  • 89bio Clinical Study Site

    Tucson, Arizona · Recruiting

  • 89bio Clinical Study Site

    Tucson, Arizona · Recruiting

  • 89bio Clinical Study Site

    Tucson, Arizona · Recruiting

  • 89bio Clinical Study Site

    Little Rock, Arkansas · Recruiting

  • 89bio Clinical Study Site

    North Little Rock, Arkansas · Recruiting

  • 89bio Clinical Study Site

    Camarillo, California · Recruiting

  • 89bio Clinical Study Site

    Canoga Park, California · Recruiting

  • 89bio Clinical Study Site

    Coronado, California · Recruiting

  • 89bio Clinical Study Site

    Fountain Valley, California · Recruiting

  • 89bio Clinical Study Site

    Fresno, California · Recruiting

  • 89bio Clinical Study Site

    Huntington Park, California · Withdrawn

  • 89bio Clinical Study Site

    La Jolla, California · Recruiting

  • 89bio Clinical Study Site

    Los Angeles, California · Recruiting

  • 89bio Clinical Study Site

    Los Angeles, California · Recruiting

  • 89bio Clinical Study Site

    Pasadena, California · Recruiting

  • 89bio Clinical Study Site

    Poway, California · Withdrawn

  • 89bio Clinical Study Site

    Redwood City, California · Recruiting

  • 89bio Clinical Study Site

    Rialto, California · Recruiting

  • 89bio Clinical Study Site

    Sacramento, California · Recruiting

  • 89bio Clinical Study Site

    Santa Ana, California · Withdrawn

  • 89bio Clinical Study Site

    Littleton, Colorado · Recruiting

  • 89bio Clinical Study Site

    Clermont, Florida · Recruiting

  • 89bio Clinical Study Site

    Fort Myers, Florida · Recruiting

  • 89bio Clinical Study Site

    Gainesville, Florida · Recruiting

  • 89bio Clinical Study Site

    Hialeah Gardens, Florida · Recruiting

  • 89bio Clinical Study Site

    Homestead, Florida · Recruiting

  • 89bio Clinical Study Site

    Jacksonville, Florida · Recruiting

  • 89bio Clinical Study Site

    Jacksonville, Florida · Recruiting

  • 89bio Clinical Study Site

    Lady Lake, Florida · Withdrawn

  • 89bio Clinical Study Site

    Lakewood Rch, Florida · Recruiting

  • 89bio Clinical Study Site

    Lehigh Acres, Florida · Recruiting

  • 89bio Clinical Study Site

    Maitland, Florida · Withdrawn

  • 89bio Clinical Study Site

    Miami, Florida · Recruiting

Showing 40 of 335 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.